Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
24.36
-0.67 (-2.68%)
Sep 3, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Market Cap
Pelthos Therapeutics has a market cap or net worth of $93.26 million as of September 3, 2026. Its market cap has increased by 36.49% in one year.
Market Cap
93.26M
Enterprise Value
142.18M
1-Year Change
36.49%
Ranking
Category
Stock Price
$24.36
ChartMarket Cap Chart
Since February 16, 2024, Pelthos Therapeutics's market cap has increased from $27.68M to $93.26M, an increase of 236.88%. That is a compound annual growth rate of 61.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 93.26M | -2.53% |
| Dec 31, 2025 | 95.69M | 2,376.40% |
| Dec 31, 2024 | 3.86M | -86.04% |
| Feb 16, 2024 | 27.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adicet Bio | 99.68M |
| Polaryx Therapeutics | 98.70M |
| Cognition Therapeutics | 96.04M |
| RenovoRx | 95.22M |
| Kalaris Therapeutics | 93.32M |
| Atara Biotherapeutics | 90.54M |
| ImmuCell | 90.10M |
| Verrica Pharmaceuticals | 90.02M |